|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-4-15
|
|
pubmed:abstractText |
Contemporary treatments for prostate cancer have probably contributed to prolonged survival in a significant number of patients. Those under androgen deprivation therapy (ADT) face, however, the danger of increased bone complications that may arise due to compromised bone integrity. Such complications include fractures due to accelerated bone resorption and pathologic fractures due to the metastases that often occur with cancer progression. We herein discuss available strategies to avoid bone loss in this patient population.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1473-6586
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
247-52
|
|
pubmed:meshHeading |
pubmed-meshheading:20224416-Androgen Antagonists,
pubmed-meshheading:20224416-Antibodies, Monoclonal,
pubmed-meshheading:20224416-Bone Density,
pubmed-meshheading:20224416-Diphosphonates,
pubmed-meshheading:20224416-Humans,
pubmed-meshheading:20224416-Male,
pubmed-meshheading:20224416-Mass Screening,
pubmed-meshheading:20224416-Osteoporosis,
pubmed-meshheading:20224416-Prostatic Neoplasms,
pubmed-meshheading:20224416-RANK Ligand
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Bone complications of androgen deprivation therapy: screening, prevention, and treatment.
|
|
pubmed:affiliation |
Department of Surgery/Urology, Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montréal, Quebec, Canada. jean-baptiste.lattouf@umontreal.ca
|
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|
